BFNHOTCLaboratory Analytical InstrumentsFiscal year ends December 31
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$6.87−0.04 (-0.58%)
Close on Oct 19, 2026
- Market cap
- $230.52M
- P/E (TTM)
- 687.2
- Dividend yield
- –
Share price
+$6.05 (+738.0%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $230.52M
- P/E ratio
- 687.2
- Price to sales
- –
- Price to book
- 100.08
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$98.25K
- EPS, diluted
- $0.01
- Book value per share
- $0.07
- Diluted shares
- 34M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
–
Net income
-$98.25K
EPS, diluted
$0.01
Reported periodTrailing twelve months